The involvement of adult stem cells originated from bone marrow in the pathogenesis of pterygia

Yonsei Medical Journal

Volumn 46, Issue 5, 2005, Pages 687-692

  Song, Young Soo ^a   Ryu, Yang Hwan ^a   Choi, Suk Rae ^a   Kim, Jae Chan ^a  

^a Chung Ang University College of Medicine   (South Korea)

Author keywords

C kit protein; CD34 antigen; Pterygium; Stem cells; STRO

Indexed keywords

CYTOKINE; GROWTH FACTOR;

ADULT; ARTICLE; CELL ACTIVITY; CELL DAMAGE; CELL SHAPE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENVIRONMENTAL FACTOR; HEALING; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; PATHOGENESIS; PTERYGIUM; RECURRENT DISEASE; SIGNAL TRANSDUCTION; SPINDLE CELL; STROMA; VASCULAR ENDOTHELIUM;

EID: 29144503768     PISSN: 05135796     EISSN: 05135796     Source Type: Journal    
DOI: 10.3349/ymj.2005.46.5.687     Document Type: Article

References (29)

1. Holland EJ, Mannis MJ. Ocular surface disease. Medical and surgical management, New York: Springer-Verlag; 2002. p.65-89.
2. Jaros PA, DeLuise VP. Pingueculae and pterygia. Sur Ophthalmol 1988;3:41-9.
3. Dushku N, John MK, Schultz GS, Reid TW. Pterygia Pathogenesis: corneal invasion by matrix metalloproteinase expressing altered limbal epithelial basal cells. Arch Ophthalmol 2001;119:695-706.
4. Maini R, Collison DJ, Maidment JM, Davies PD, Wormstone IM. Pterygial derived fibroblasts express functionally active histamine and epidermal growth factor receptors. Exp Eye Res 2002;74:237-44.
5. Saw SM, Tan D. Pterygium: prevalence, demography and risk factors. Ophthalmic Epidemiol 1999;6:219-28.
6. Austin P, Jakobiec FA, Iwamoto T. Elastodysplasia and elastodystrophy as the pathologic bases of ocular pterygia and pinguecula. Ophthalmology 1983;90:96-109.
7. Tan DT, Tang WY, Liu YP, Goh HS, Smith DR. Apoptosis and apoptosis related gene expression in normal conjunctiva and pterygium. Br J Ophthalmol 2000;84:212-6.
8. Chowers I, Pe'er J, Zamir E, Livni N, Ilsar M, Frucht-Pery J. Proliferative activity and p53 expression in primary and recurrent pterygia. Ophthalmology 2001;108: 985-8.
9. Tan DT, Lim AS, Goh HS, Smith DR. Abnormal expression of the p53 tumor suppressor gene in the conjunctiva of patients with pterygium. Am J Ophthalmol 1997; 123:404-5.
10. Weinstein O, Rosenthal G, Zirkin H, Monos T, Lifshitz T, Argov S. Overexpression of p53 tumor suppressor gene in pterygia. Eye 2002;16:619-21.
11. Varinli S, Varinli I, Koksal Erkisi M, Doran F. Human papillomavirus in pterygium. Cent Afr J Med 1994;40: 24-6.
12. Dick JE. Stem cells: Self-renewal writ in blood. Nature 2003;423:231-3.
13. Horwitz EM. Stem cell plasticity: a new image of the bone marrow stem cell. Curr Opin Pediatr 2003;15:32-7.
14. Ohgushi H, Kitamura S, Kotobuki N, Hirose M, Machida H, Muraki K, et al. Clinical application of marrw mesenchymal stem cells for hard tissue repair. Yonsei Med J 2004;45(Suppl):61-7.
15. Nowicki MO, Pawlowski P, Fischer T, Hess G, Pawlowski T, Skorski T. Chronic myelogenous leukemia molecular signature. Oncogene 2003;22:3952-63.
16. Pathak S. Organ- and tissue-specific stem cells and carcinogenesis. Anticancer Res 2002;22:1353-6.
17. Tu SM, Lin SH, Logothetis CJ. Stem-cell origin of metastasis and heterogeneity in solid tumours. Lancet Oncol 2002;3:508-13.
18. Risitano AM, Holada K, Chen G, Simak J, Vostal JG, Young NS, et al. CD34+ cells from paroxysmal nocturnal hemoglobinuria (PNH) patients are deficient in surface expression of cellular prion protein (PrPc). Exp Hematol 2003;31:65-72.
19. Nakakuma H, Kawakuchi T. Pathogenesis of selective expansion of PNH clones. Int J Hematol 2003;77:121-4.
20. Walshe R, Esser P, Wiedemann P, Heimann K. Proliferative retinal diseases: myofibroblasts cause chronic vitreoretinal traction. Br J Ophthalmol 1992;76: 550-2.
21. Piras F, Moore PS, Ugalde J, Perra MT, Scarpa A, Sirigu P. Detection of human papillomavirus DNA in pterygia from different geographical regions. Br J Ophthalmol 2003;87:864-6.
22. Detorakis ET, Sourvinos G, Spandidos DA. Detection of herpes simplex virus and human papilloma virus in ophthalmic pterygium. Cornea 2001;20:164-7.
23. Krause DS, Ito T, Fackler MJ, Smith OM, Collector MI, Sharks SJ, et al. Characterization of murine CD34, a marker for hematopoietic progenitor and stem cells. Blood 1994;84:691-701.
24. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000;95: 952-8.
25. Gronthos S, Graves SE, Ohta S, Simmons PJ. The STRO1+ fraction of adult human bone marrow contains the osteogenic precursors. Blood 1994;84:4164-73.
26. Dennis JE, Carbillet JP, Caplan AI, Charbord P. The STRO-1+ marrow cell population is multipotential. Cell Tissue Organs 2002;170:73-82.
27. Lee SB, Li DQ, Tan DT, Meller DC, Tseng SC. Suppression of TGF-beta signaling in both normal conjunctival fibroblasts and pterygial body fibroblasts by amniotic membrane. Curr Eye Res 2000;20:325-34.
28. Di Girolamo N, Kumar RK, Coroneo MT, Wakefield D. UVB-mediated induction of interleukin-6 and -8 in pterygia and cultured human pterygium epithelial cells. Invest Ophthalmol Vis Sci 2002;43:3430-7.
29. Li DQ, Lee SB, Gunja-Smith Z, Liu Y, Solomon A, Meller D, et al. Overexpression of collagenase (MMP-1) and stromelysin (MMR-3) by pterygium head fibroblasts. Arch Ophthalmol 2001;119:71-80.